When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
The most important facts at a glance
Dermatophytosis, also known as ringworm, is a fungal infection in dogs caused by specialized fungi that can break down keratin. The most common pathogens include the fungal genera Microsporum and Trichophyton. Transmission usually occurs through direct contact with infected animals or contaminated objects. Fungi can survive in the environment for months, increasing the risk of infection. Dogs with a weakened immune system or young dogs are particularly susceptible to the infection.
Typical symptoms include circular Hair loss, dry skin, Itching, and poor coat quality. Diagnosis is often made through a clinical examination and microscopic analysis of hair and skin flakes. A culture of skin samples may also be performed to identify the fungus. Treatment commonly includes antifungal shampoos or creams as well as systemic antifungals. Treatment often lasts several weeks to ensure the infection is completely eliminated.
The prognosis for dogs with dermatophytosis is generally good, especially with early diagnosis and treatment. Prevention includes minimizing contact with infected animals and regularly disinfecting objects. A balanced diet and veterinary check-ups can strengthen the immune system and reduce the risk of infection. Newly adopted animals should initially be kept in quarantine and checked for signs of the disease.
Causes
Dermatophytes are specialized fungi that can break down keratin, the main protein in skin and hair. The three main genera of these fungi are Trichophyton, Microsporum, and Epidermophyton. In dogs, Microsporum canis, Microsporum gypseum, and Trichophyton mentagrophytes are the most common pathogens.
These fungi can survive and multiply in keratinized tissues. Transmission usually occurs through direct contact with infected animals or contaminated objects such as brushes, combs, bedding, or even furniture. Dermatophytes can remain viable in the environment for months, increasing the risk of infection.
Another factor that can contribute to infection is the dog’s immune system. Dogs with a weakened immune system—whether due to illness, stress, or inadequate nutrition—are more susceptible to dermatophytosis. Young dogs are also particularly at risk because their immune defenses are not yet fully developed.
Symptoms
- Inflammation of the Skin
- Paronychia
- Claws with Altered Horn Quality (Dry, Brittle, Deformed, Shortened, Rough, Soft)
- Nail Discoloration
- Brittle Claws
- Areas of Alopecia
- Crusts
- Pustules on the Skin
- Purulent Pustules (Pyoderma)
- Chronic Inflammation of the skin
- Thickened Skin (Pachyderma)
- Cutaneous hyperpigmentation
Symptoms of dermatophytosis in dogs can vary depending on the severity of the infection. The condition often starts with small, circular, hairless patches on the skin, known as classic “ringworm” lesions. These Lesions can spread and increase in number.
Affected skin areas may be reddened, scaly, or crusted. In some cases, pustules or blisters may also develop. The itching can vary greatly; some dogs show little sign of itching, while others scratch intensely.
In severe cases, the claws can also be affected, leading to thickening and deformation. With systemic spread, other areas of the body such as the head or limbs can also be affected.
Diagnosis
Diagnosis of dermatophytosis often begins with a thorough clinical examination and medical history. The veterinarian will ask about possible contact with infected animals or contaminated environments.
A common diagnostic method is to examine the hair and skin scales under a microscope for fungal spores and hyphae. Another method is to culture skin samples on a special nutrient medium to allow the growth and identification of the fungi. However, this can take several weeks.
A Wood’s lamp, which emits ultraviolet light, can also be used to identify affected hairs, as some dermatophytes fluoresce. However, not all pathogens are visible under a Wood’s lamp.
Therapy
Treatment of dermatophytosis in dogs usually involves a combination of topical and systemic antifungals. Topical treatments such as antifungal shampoos or creams are often used to reduce the number of fungi on the skin.
In severe or widespread cases, systemic antifungals may be necessary. These medications are given oral and help fight the fungus throughout the body. Commonly used medications include griseofulvin, itraconazole, and terbinafine.
Treatment often needs to be continued for several weeks, even after symptoms subside, to ensure the infection is completely eliminated. Regular monitoring by the veterinarian is important to assess treatment progress.
Prognosis and follow-up care
The prognosis for dogs with dermatophytosis is generally good, especially if the infection is diagnosed and treated early. Most dogs respond well to treatment and recover fully.
If the infection is not treated in time, or in dogs with a weakened immune system, healing may take longer and complications can occur. However, a full recovery is possible with the right treatment and care.
Prevention
Prevention of dermatophytosis in dogs involves minimizing contact with infected animals and contaminated environments. Regular hygiene practices, such as cleaning and disinfecting dog beds, brushes, and other items, can help reduce the risk of infection.
Strengthening the immune system through a balanced diet and regular veterinary check-ups can also help lower the risk of infection. If there is an outbreak in a household with multiple pets, each animal should be checked for an infection and treated if necessary to prevent spread.
It’s also important to keep newly adopted or purchased animals in quarantine at first and check them for signs of dermatophytosis before allowing contact with other animals.
Outlook on current research
Research is increasingly focusing on dermatomyositis as an interface disease of the skin, skeletal muscle, and vascular endothelium. Genetic studies in Collies and Shelties identify risk haplotypes and signaling pathways that indicate a misdirected interferon response (type I interferonopathy). This leads to a paradigm shift: away from unspecific immunosuppression, towards targeted immunomodulators. JAK inhibitors (down-regulation of interferon-stimulated genes), calcineurin inhibitors in optimized topical/systemic regimens, and IVIG in severe muscle courses are being prospectively evaluated. In parallel, working groups are investigating vasoprotectives (e.g. pentoxifylline) and omega-3-enriched diets, which could favorably influence microcirculation and inflammation.
A multidimensional profile is emerging diagnostically: skin/muscle histopathology (vasculitic changes, perifascicular atrophy), electromyography, and, in addition, serological interferon signatures and transcriptomic markers. The goal is early, non-invasive biomarkers that predict therapy response and control escalation steps. Imaging (high-resolution ultrasound of the muscles, MRI for unclear lameness) is interpreted more functionally, e.g. to quantify inflammatory activity.
A second focus is on relapse prophylaxis: standardized photoprotection, strengthening of the skin barrier, structured rehab (dosed muscle work, avoidance of triggers) and digital symptom diaries for early detection of flare-ups. In the long term, the aim is to achieve stratified treatment algorithms that integrate genetics, interferon signature, clinic, and imaging – with the aim of reducing flare-ups, minimizing scarring, and sustainably stabilizing the quality of life.